Supplementary Prognostic Variables for Pleural Mesothelioma A Report from the IASLC Staging Committee

Creative Commons License

Pass H. I., Giroux D., Kennedy C., Ruffini E., KAYI CANGIR A., Rice D., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.9, sa.6, ss.856-864, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 6
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1097/jto.0000000000000181
  • Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.856-864
  • Anahtar Kelimeler: Mesothelioma, Surgery, Prognosis, Registry, Staging, TO-LYMPHOCYTE RATIO, PHASE-II TRIALS, MALIGNANT MESOTHELIOMA, EXTRAPLEURAL PNEUMONECTOMY, INTERNATIONAL-ASSOCIATION, LUNG-CANCER, SURVIVAL, VALIDATION, EXPRESSION, VOLUME
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: The staging system for malignant pleural mesothelioma is controversial. To revise this system, the International Association for the Study of Lung Cancer Staging Committee developed an international database. This report analyzes prognostic variables in a surgical population, which are supplementary to previously published CORE variables (stage, histology, sex, age, and type of procedure).